23andMe to delist from Nasdaq, deregister with SEC

A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024.

Justin Sullivan | Getty Images

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.

The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for for Chapter 11 bankruptcy protection in March.

This is breaking news. Please refresh for updates.

Source

Technology

Led by Texas, New Hampshire, U.S. states race to prove they can put bitcoin on public balance sheet

January 17, 2026

Led by Texas and New Hampshire, U.S. states across the national map, both red and blue in political stripes, are developing bitcoin strategic reserves and bringing cryptocurrencies onto their books through additional state finance and budgeting measures. Texas recently became the first state to purchase bitcoin after a legislative effort that began in 2024, but […]

Technology

Google files to appeal search monopoly case

January 16, 2026

Google CEO Sundar Pichai during the press conference after his meeting with Polish PM Donald Tusk at Google for Startups Campus In Warsaw in Warsaw, Poland, on Feb. 13, 2025. Jakub Porzycki | Nurphoto | Getty Images Google on Friday filed to appeal a federal judge’s ruling that the company held an illegal monopoly in […]

Technology

OpenAI to begin testing ads on ChatGPT in the U.S.

January 16, 2026

OpenAI CEO Sam Altman visits “Making Money With Charles Payne” at Fox Business Network Studios in New York on Dec. 4, 2024. Mike Coppola | Getty Images OpenAI on Friday announced it will begin testing ads within ChatGPT in the coming weeks, a highly anticipated decision that could kickstart a lucrative new revenue stream for […]